MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$5,761,940
EPS
-$1.52
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
3,282,557
3,134,810
2,395,471.5*
3,110,752
General and administrative
2,379,819
2,266,110
6,984,093*
2,618,679
Total operating expenses
5,662,376
5,400,920
9,379,564.5
5,729,431
Loss from operations
-5,662,376
-5,400,920
-9,379,564.5*
-5,729,431
Interest expense, net
-98,387
-71,166
-45,058.5*
-62,340
Change in fair value of warrants
1,177
-25,831
4,622.5*
-64,959
Net loss
-5,761,940
-5,446,255
-9,429,245.5
-5,726,812
Basic EPS
-1.52
-1.61
0.025
-0.03
Diluted EPS
-1.52
-1.61
0.025
-0.03
Basic Average Shares
3,829,365
3,486,215
-370,376,517
196,028,784
Diluted Average Shares
3,829,365
3,486,215
-370,376,517
196,028,784
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$5,761,940
(-4.69%↓ Y/Y)
Loss from operations
-$5,662,376
(-4.00%↓ Y/Y)
Interest expense, net
-$98,387
(-158.69%↓ Y/Y)
Change in fair value of
warrants
$1,177
(-94.50%↓ Y/Y)
Total operating
expenses
$5,662,376
(4.00%↑ Y/Y)
Research and development
$3,282,557
(21.58%↑ Y/Y)
General and
administrative
$2,379,819
(-13.29%↓ Y/Y)
Buy us a coffee
Tevogen Inc. (TVGNW)
Tevogen Inc. (TVGNW)